Expert Q&A Speakers

 

  • Daniel J. George, MD

    Daniel J. George, MD

    Daniel J. George, MD

    Professor of Medicine and Surgery, Director, GU Oncology

    Daniel J. George, MD, is a professor of medicine and surgery in the Divisions of Medical Oncology and Urology at Duke University School of Medicine in Durham, North Carolina. He also has appointments in the Duke Clinical Research Institute and the Duke Cancer Institute, where he is the director of genitourinary (GU) oncology. Dr George’s areas of research include new drug development and biomarkers of GU cancers with an emphasis on signal transduction pathways and angiogenesis. He leads the Duke site for the Department of Defense Prostate Cancer Clinical Trials Consortium, specializing in Phase I and II studies in prostate cancer. Dr George is an internationally recognized clinical researcher and thought leader in GU malignancies, with over 150 peer-reviewed publications.
  • Neal D. Shore, MD, FACS

    Neal D. Shore, MD, FACS

    Neal D. Shore, MD, FACS

    Medical Director, CPI

    Neal Shore, MD, is the Medical Director for the Carolina Urologic Research Center and practices with Atlantic Urology Clinics in Myrtle Beach, South Carolina. Dr. Shore has conducted more than 400 clinical trials, focusing on GU Oncology indications. He is the Chief Medical Officer, Surgery/Urology, for GenesisCare,US. Dr. Shore serves on the SITC Guidelines Committee for Bladder Cancer and the boards of the Bladder Cancer Advocacy Network and the Duke Global Health Institute. He is the Chair of the LUGPA Education Committee. Dr. Shore is on the editorial boards of Reviews in Urology, Urology Times, Chemotherapy Advisor, OncLive, PLOS ONE, Urology Practice, World Journal of Urology, and serves as Editor for Everyday Urology-Oncology. Also, he’s a Fellow of the American College of Surgeons.